This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of accessory sinuses
C3_ACCESSORY_SINUS
paranasal sinus neoplasm: A benign or malignant neoplasm that affects the paranasal sinuses. Representative examples of benign neoplasms include Schneiderian papilloma and salivary gland-type adenoma. Representative examples of malignant neoplasms include carcinoma and lymphoma.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
98 |
4. Check minimum number of eventsNone |
98 |
5. Include endpointsNone |
98 |
6. Filter based on genotype QC (FinnGen only) |
86 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of accessory sinuses
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of accessory sinuses, including Hilmo
- Malignant neoplasm of nasal cavity and sinuses
- Malignant neoplasm of nasal cavity and sinuses, including Hilmo
- Malignant neoplasm of respiratory system and intrathoracic organs
- Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 86 | 36 | 50 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 64.98 | 63.06 | 66.36 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 90
- Matched controls
- 900
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
48.4
42
*
C31.0
ICD-10 Finland
Malignant neoplasm: Maxillary sinus
+∞
38.3
34
*
WF002
NOMESCO Finland
Radical radiotherapy
464.9
33.2
31
*
A03FA01
ATC
metoclopramide; systemic, rectal
12.7
31.9
42
58
UDH02
NOMESCO Finland
Rhinopharyngoscopy
15.8
30.4
31
29
N02AA05
ATC
oxycodone; systemic
10.2
27.0
43
74
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
25.2
23
*
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
+∞
25.2
23
*
H02AB02
ATC
dexamethasone; systemic
75.9
24.7
27
5
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
22.9
21
*
C31.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of accessory sinuses
+∞
20.6
19
*
8070/3-C31.0
ICD-O-3
Squamous cell carcinoma, NOS, of maxillary sinus
+∞
20.6
19
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
237.5
19.3
19
*
WZC00
NOMESCO Finland
Treatment plan or consultation
6.8
19.0
52
150
UDM02
NOMESCO Finland
Sinoscopy
84.4
18.6
20
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
18.3
17
*
D38.51
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other accessory sinus
+∞
18.3
17
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
18.3
17
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
221.9
18.2
18
*
DHA10
NOMESCO Finland
Biopsy of cavity of nose
63.4
17.8
20
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
17.2
16
*
XX3DW
NOMESCO Finland
Time consuming IT work
19.8
16.6
25
17
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
192.0
16.0
16
*
A04AA01
ATC
ondansetron; systemic, rectal
36.1
16.0
20
7
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
+∞
15.0
14
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
13.9
13
*
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
+∞
13.9
13
*
JN4BD
NOMESCO Finland
Extensive body CT
23.6
13.6
19
10
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
12.8
12
*
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
+∞
12.8
12
*
SAA03
NOMESCO Finland
Extended examination of mouth
4.7
12.2
51
195
Z51.5
ICD-10 Finland
Palliative care
13.9
11.8
20
18
DPA30
NOMESCO Finland
Sphenotomy
136.8
11.7
12
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
136.8
11.7
12
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
11.7
11
*
D38.50
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of maxillary sinus
+∞
11.7
11
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
6.2
11.5
23
47
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
25.3
11.1
15
7
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
25.3
11.1
15
7
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
25.3
11.1
15
7
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
13.0
10.9
19
18
L03AA13
ATC
pegfilgrastim; parenteral
123.8
10.7
11
*
EBB10
NOMESCO Finland
Insertion of dental implant
123.8
10.7
11
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
10.6
10
*
C31.9
ICD-10 Finland
Malignant neoplasm: Accessory sinus, unspecified
+∞
10.6
10
*
L03AA02
ATC
filgrastim; parenteral
+∞
10.6
10
*
GD6AD
NOMESCO Finland
CT of chest and neck
+∞
10.6
10
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.5
9.7
22
50
EBB15
NOMESCO Finland
Insertion of dental implant abutment
+∞
9.5
9
*
C31.1
ICD-10 Finland
Malignant neoplasm: Ethmoidal sinus
+∞
9.5
9
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
9.5
9
*
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
+∞
9.5
9
*
EEB10
NOMESCO Finland
Maxillectomy
+∞
9.5
9
*
EEB00
NOMESCO Finland
Partial excision of maxilla
+∞
9.5
9
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
9.5
9
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
9.5
9
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
41.2
9.2
11
*
GBB00
NOMESCO Finland
Tracheostomy
41.2
9.2
11
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.2
9.0
32
105
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.3
8.9
30
94
JDB10
NOMESCO Finland
Percutaneous gastrostomy
55.6
8.9
10
*
WZC30
NOMESCO Finland
Teaching
4.6
8.8
25
69
ZX090
NOMESCO Finland
Other technic of radiotherapy
98.9
8.6
9
*
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
98.9
8.6
9
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
+∞
8.5
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.5
8
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
13.5
8.4
14
12
WW500
NOMESCO Finland
Blood transfusion
19.5
8.3
12
7
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
8.5
7.9
17
24
EP1AE
NOMESCO Finland
Neck ultrasound examination
11.6
7.9
14
14
WX402
NOMESCO Finland
General anaesthesia
3.9
7.8
29
97
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
87.0
7.5
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.9
7.5
19
47
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
+∞
7.4
7
*
AAE99
NOMESCO Finland
Other operation by cranial base approach
+∞
7.4
7
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
7.4
7
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
7.4
7
*
ZZC00
NOMESCO Finland
Graft of fascia
+∞
7.4
7
*
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
+∞
7.4
7
*
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
+∞
7.4
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.4
7
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.3
7.4
47
222
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.3
7.2
51
255
R04.0
ICD-10 Finland
Epistaxis
5.0
7.1
17
40
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
15.4
7.1
11
8
A07AA02
ATC
nystatin; oral
8.3
7.1
15
21
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
24.7
6.8
9
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
13.7
6.8
11
9
DHB40
NOMESCO Finland
Conchotomy
74.9
6.5
7
*
ZXC95
NOMESCO Finland
Use of surgical navigator
28.9
6.3
8
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
28.9
6.3
8
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
28.9
6.3
8
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
+∞
6.3
6
*
8720/3-C31.0
ICD-O-3
Malignant melanoma, NOS, of maxillary sinus
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
+∞
6.3
6
*
EEB20
NOMESCO Finland
Hemimaxillectomy
+∞
6.3
6
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
6.3
6
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
6.3
6
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.0
6.1
12
15
XW000
NOMESCO Finland
Bone marrow biopsy
16.4
6.0
9
6
SBB10
NOMESCO Finland
Dental impressions
6.4
6.0
15
27
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
24
48
6.45
12.28
2.8
2.3
0.24
0.22
g/l
0.57
24
38
61
360
3.16
6.18
10.5
5.5
1.22
1.21
mmol/l
0.83
50
311
55
308
3.02
6.09
9.3
5.4
1.21
1.21
mmol/l
0.20
50
281
35
159
2.97
5.58
3.5
1.9
—
—
—
0
0
8
5
17.34
5.52
1.0
1.0
—
—
—
0
0
15
42
4.09
5.01
8.3
9.7
1.23
1.18
%
0.07
15
42
11
17
7.20
4.94
1.6
1.4
—
—
—
0
0
24
95
3.08
4.79
4.1
4.9
0.98
1.03
mmol/l
0.33
24
86
60
383
2.70
4.72
22.5
6.7
3.77
4.12
e9/l
0.67
55
333
15
44
3.89
4.70
8.5
4.4
1.23
1.21
mmol/l
0.99
15
36
7
5
15.00
4.65
7.7
1.2
—
—
—
0
0
10
16
6.88
4.43
2.8
2.9
1.06
1.93
mg/l
—
10
11
50
304
2.45
4.19
5.0
2.4
—
—
estimate
—
0
0
10
18
6.10
4.11
1.7
2.8
—
—
—
0
0
8
11
7.85
3.95
1.4
1.4
5.01
3.21
g/l
—
8
11
14
40
3.95
3.82
9.1
9.9
0.57
0.65
%
0.28
14
40
8
14
6.15
3.42
2.3
1.3
—
—
—
0
0
8
14
6.15
3.42
1.9
1.1
82.63
87.07
%
—
8
14
14
49
3.20
3.37
1.4
1.8
—
—
—
0
0
6
8
7.93
3.10
3.3
1.5
—
—
—
0
0
5
5
10.48
3.01
2.2
1.4
—
—
—
0
0
6
9
7.04
2.91
1.8
1.0
—
—
—
0
0
55
686
0.49
2.60
4.8
6.3
2.73
2.59
mmol/l
0.34
50
640
6
11
5.75
2.58
3.3
1.4
—
—
—
0
0
6
11
5.75
2.58
3.5
1.3
—
—
—
0
0
5
7
7.47
2.58
1.6
1.1
—
—
—
0
0
19
93
2.32
2.43
6.7
6.0
104.89
104.62
mmol/l
0.08
19
93
5
9
5.81
2.24
2.0
1.0
—
—
—
0
0
6
15
4.20
2.07
1.7
1.5
—
—
—
0
0
6
15
4.20
2.07
6.3
2.9
27.83
9.89
u/ml
—
6
9
12
53
2.46
1.90
5.0
1.7
78.60
69.61
ml/min/173m2
—
5
18
15
74
2.23
1.88
6.1
3.4
—
—
—
0
0
5
12
4.34
1.85
1.4
1.2
222.80
188.92
%
—
5
12
34
232
1.75
1.70
3.0
2.8
—
—
—
0
0
6
19
3.31
1.69
1.5
1.1
90.00
2.43
e6/l
—
6
14
5
14
3.71
1.64
1.4
2.6
—
—
—
0
0
6
20
3.14
1.61
1.5
1.3
6172.00
334.07
e6/l
—
6
15
16
266
0.52
1.60
5.9
4.4
1.35
8.71
mg/mmol
3.02
11
177
56
664
0.59
1.58
4.7
5.3
6.05
6.06
mmol/l
0.04
51
608
18
103
1.93
1.55
3.8
1.6
—
—
—
0
0
14
73
2.09
1.54
3.6
1.7
—
—
—
0
0
6
21
2.98
1.53
1.0
1.2
885.00
383.19
mg/l
—
6
21
9
37
2.59
1.53
2.2
1.3
—
—
—
0
0
54
644
0.60
1.52
4.1
4.7
1.32
1.32
mmol/l
0.01
48
590
6
22
2.85
1.46
1.2
1.3
—
—
—
0
0
5
16
3.24
1.46
1.0
1.2
4.26
4.14
mmol/l
—
5
16
56
656
0.61
1.37
5.2
7.2
39.42
40.17
mmol/mol
0.23
49
619
14
79
1.91
1.25
3.6
1.6
—
—
—
0
0
21
136
1.71
1.23
1.5
1.8
1122.03
1169.92
nmol/l
0.09
16
110
30
216
1.58
1.17
7.0
2.6
26.67
29.80
u/l
0.57
30
202
5
21
2.46
1.10
1.8
1.6
—
—
—
0
0
7
33
2.21
1.08
3.1
1.5
—
—
—
0
0
5
22
2.34
1.04
3.6
1.6
—
—
—
0
0
20
139
1.56
0.89
1.6
1.5
0.94
1.01
mg/l
0.08
14
105
26
196
1.46
0.80
2.1
2.1
2.97
2.83
mg/l
0.23
20
167
0
27
0.00
0.79
0.0
1.6
—
2.60
—
0
18
30
370
0.72
0.73
5.0
3.8
0.00
0.00
estimate
—
10
80
30
365
0.73
0.65
4.9
3.8
0.00
0.00
estimate
—
10
84
14
99
1.49
0.58
2.2
2.7
1.14
0.85
e6/l
—
9
46
9
59
1.58
0.57
1.8
2.7
0.86
0.24
e6/l
—
9
53
19
244
0.72
0.57
4.6
4.0
20.63
24.74
%
—
8
123
30
359
0.75
0.57
4.9
3.8
0.00
0.00
estimate
—
10
84
28
338
0.75
0.56
2.3
2.1
81.67
98.06
pmol/l
0.97
16
172
23
281
0.76
0.49
5.7
3.7
0.00
0.00
estimate
—
8
71
59
637
0.79
0.44
6.6
5.1
2.11
1.96
mu/l
0.32
52
579
31
263
1.27
0.44
2.2
3.0
693.38
1143.32
ng/l
0.74
26
221
0
15
0.00
0.41
0.0
3.9
—
28.29
—
0
7
0
15
0.00
0.41
0.0
1.3
—
0.80
—
0
15
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
5
77
0.63
0.37
1.0
1.4
—
—
—
0
0
18
211
0.82
0.26
6.7
3.6
0.00
0.00
estimate
—
10
74
36
391
0.87
0.22
2.9
2.5
—
—
—
0
0
5
42
1.20
0.22
1.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
5.06
—
0
7
0
14
0.00
0.20
0.0
1.1
—
20.40
—
0
5
54
565
0.89
0.16
35.5
17.9
329.93
332.33
g/l
1.20
54
557
7
85
0.81
0.15
12.9
5.9
—
—
—
0
0
29
312
0.90
0.14
4.1
4.0
40.26
156.77
ng/l
0.57
23
234
17
189
0.88
0.13
3.7
2.5
342.35
362.36
umol/l
0.51
17
163
19
203
0.92
0.07
6.1
3.6
0.00
0.00
estimate
—
9
68
54
542
0.99
0.00
41.5
17.3
14.40
13.66
%
3.63
54
534
10
97
1.03
0.00
1.2
1.5
—
—
—
0
0
21
207
1.02
0.00
2.2
1.7
14.61
20.07
nmol/l
0.91
15
180
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
17.82
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
55.61
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
2.48
—
0
6
7
78
0.89
-0.00
2.6
2.9
3.59
2.01
mmol/l
—
7
61
5
57
0.87
-0.00
2.8
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
7
75
0.93
-0.00
2.6
3.1
5.79
5.74
kpa
—
7
69
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
74.15
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_ACCESSORY_SINUS – Malignant neoplasm of accessory sinuses
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).